Gdansk, Poland

Tomasz Sitar

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Polpharma Biologics S.a.. Active years: 2024.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Tomasz Sitar in Cell Culture Methods

Introduction

Tomasz Sitar is an accomplished inventor based in Gdansk, Poland. He has made significant contributions to the field of biotechnology, particularly in the area of cell culture methods. His innovative approach aims to enhance the production of recombinant proteins, which are crucial for various applications in medicine and research.

Latest Patents

Tomasz Sitar holds a patent for "Methods of cell culture." This invention provides a method for reducing the amount of acidic species and/or increasing the amount of basic species in a composition comprising a recombinant protein. It also focuses on increasing the specific production rate of mammalian cells expressing a recombinant protein. The method simplifies subsequent clarification and purification of the recombinant protein by culturing mammalian cells in a cell culture medium that includes citrulline. He has 1 patent to his name.

Career Highlights

Tomasz Sitar is currently employed at Polpharma Biologics S.A., a leading company in the biopharmaceutical industry. His work at Polpharma Biologics involves developing advanced methods for protein production, which are essential for the development of therapeutic agents.

Collaborations

Some of his notable coworkers include Lenneke De Winter and Louis Boon. Their collaboration contributes to the innovative environment at Polpharma Biologics, fostering advancements in biotechnological research.

Conclusion

Tomasz Sitar's contributions to cell culture methods represent a significant advancement in biotechnology. His innovative patent and work at Polpharma Biologics highlight his commitment to improving recombinant protein production.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…